8-K - Emmaus Life Sciences, Inc. - 5.02 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001213900-26-045250
Filing Date: 2026-04-17
Accepted: 2026-04-17 17:16:23
Documents: 11
Period of Report: 2026-04-16
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Emmaus Life Sciences, Inc. (Filer) CIK : 0000822370 (see all company filings) EIN. : 870419387 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 26872628 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | CURRENT REPORT | ea028688101-8k_emmauslife.htm iXBRL | 8-K
2 | XBRL SCHEMA FILE | emma-20260416.xsd | EX-101.SCH
3 | XBRL LABEL FILE | emma-20260416_lab.xml | EX-101.LAB
4 | XBRL PRESENTATION FILE | emma-20260416_pre.xml | EX-101.PRE